Understanding OUR Cytokine-Based Immunotherapy Candidates Our Dedication extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, especially for cancers where cure selections remain limited. Make use of the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Examine Our https://financefeeds.com/equilend-appoints-fintech-expert-nick-delikaris-as-chief-product-officer/